Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Fischl

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Annals of Internal Medicine|March 1, 1983
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency stateA E Pitchenik, M A Fischl, G M Dickinson, et al.
Annals of Internal Medicine|January 1, 1992
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II studyT C Meng, M A Fischl, A M Boota, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trailW P Parks, E S Parks, M A Fischl, et al.
The Journal of Infectious Diseases|April 1, 1994
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology LaboratoriesV DeGruttola, L A Beckett, R W Coombs, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
Journal of Acquired Immune Deficiency Syndromes|March 1, 1993
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials GroupM A Fischl, S E Krown, K P O'Boyle, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 InvestigatorsX J Zhou, L B Sheiner, R T D'Aquila, et al.
The Journal of Infectious Diseases|September 1, 1993
Tuberculosis symposium: emerging problems and promiseJ J Ellner, A R Hinman, S W Dooley, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|March 1, 1983
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency stateA E Pitchenik, M A Fischl, G M Dickinson, et al.
Annals of Internal Medicine|January 1, 1992
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II studyT C Meng, M A Fischl, A M Boota, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trailW P Parks, E S Parks, M A Fischl, et al.
The Journal of Infectious Diseases|April 1, 1994
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology LaboratoriesV DeGruttola, L A Beckett, R W Coombs, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
Journal of Acquired Immune Deficiency Syndromes|March 1, 1993
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials GroupM A Fischl, S E Krown, K P O'Boyle, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 InvestigatorsX J Zhou, L B Sheiner, R T D'Aquila, et al.
The Journal of Infectious Diseases|September 1, 1993
Tuberculosis symposium: emerging problems and promiseJ J Ellner, A R Hinman, S W Dooley, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
Pageof 11